β‐Adrenergic treatment of hyperkalemic periodic paralysis

Publisher Website
Google Scholar
Abstract
In a patient with hyperkalemic periodic paralysis, metaproterenol prevented muscular weakness and hyperkalemia in periods of rest after exercise. During a severe attack, the drug rapidly corrected hyperkalemia and seemed to enhance the return of strength. The action of metaproterenol may involve a beta-adrenergic-mediated increase of potassium transport via the sodium-potassium pump.

This publication has 0 references indexed in Scilit: